177583-27-6 Usage
Description
t-Butyl (trans-4-aminomethylcyclohexyl)carbamate is a chemical compound with a complex structure, characterized by its carbamate functional group and a cyclohexyl ring with an aminomethyl side chain. It is known for its potential applications in various industries due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
t-Butyl (trans-4-aminomethylcyclohexyl)carbamate is used as a raw material intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a versatile building block in the development of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Chemical Industry:
In the chemical industry, t-Butyl (trans-4-aminomethylcyclohexyl)carbamate can be utilized as an intermediate in the production of various specialty chemicals, such as agrochemicals, dyes, and other fine chemicals. Its reactivity and structural features make it a valuable component in the synthesis of complex molecules with specific applications.
Please note that the provided materials only mention the use of t-Butyl (trans-4-aminomethylcyclohexyl)carbamate as a raw material intermediate for pharmaceutical and chemical industries. Additional applications or reasons for its use may exist but are not provided in the given information.
Check Digit Verification of cas no
The CAS Registry Mumber 177583-27-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,5,8 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 177583-27:
(8*1)+(7*7)+(6*7)+(5*5)+(4*8)+(3*3)+(2*2)+(1*7)=176
176 % 10 = 6
So 177583-27-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H24N2O2/c1-12(2,3)16-11(15)14-10-6-4-9(8-13)5-7-10/h9-10H,4-8,13H2,1-3H3,(H,14,15)/t9-,10-
177583-27-6Relevant articles and documents
AMINE-DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF
-
Page/Page column 22, (2010/12/26)
This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I): formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted lower alkyl,Y is —S(O)n- wherein n is 1 or 2, or —CO—,R2 is hydrogen or lower alkyl, R7 is hydrogen or lower alkyl,X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, andZ is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: Design, synthesis, and biological activity
Xue, Fengtian,Seto, Christopher T.
, p. 8467 - 8487 (2008/02/05)
Three series of cyclic ketone inhibitors were synthesized and evaluated against the serine protease plasmin. Peptide inhibitors that incorporated 3-oxotetrahydrofuran and 3-oxotetrahydrothiophene 1,1-dioxide groups had the highest activities. Alkylamino substituents, which were designed to bind in the S1 subsite of plasmin, were attached to the inhibitors. Compounds 5c and 5g, which incorporated 6-aminohexyl substituents, were found to be optimal and demonstrated IC50 values in the low micromolar range. Incorporating conformationally constrained peptide segments into the inhibitors did not improve their activities.